Identification of potentially deleterious mutations in gastric cancer using patient-derived xenograft models

Key Points

Prioritized mutations include PTPRK, PIK3CB, LRP1B, and IGF2R, providing actionable insights into gastric cancer therapy.
Mutations were identified through integrated analysis of longitudinal whole-exome sequencing from primary tumors and PDXs.
Patient-derived xenograft models effectively preserve the biological and genetic characteristics of gastric tumors, highlighting their significance.
Finding conserved mutations offers a new understanding of gastric cancer, with implications for targeted treatment strategies.

Abstract

This study demonstrated that PDX models effectively preserve the biological and genetic characteristics of primary gastric tumors, underscoring their utility in studying tumor heterogeneity. The integrated analysis of longitudinal WES data from primary tumors and matched PDXs enabled the identification of a core set of conserved, potentially deleterious mutations. The four prioritized mutations (PTPRK, PIK3CB, LRP1B, and IGF2R) provide new insights into the genetic landscape of gastric cancer and represent promising candidates for the development of targeted therapeutic strategies.

Bookmark

View Full Paper

Bookmark

View Full Paper

Identification of potentially deleterious mutations in gastric cancer using patient-derived xenograft models

Key Points

Abstract

Cite This Study

Also Consider

Also Consider